Biobehavioral Intervention in Gynecologic Oncology Patients
Primary Purpose
Neoplasms, Ovarian Neoplasms, Uterine Neoplasms
Status
Completed
Phase
Phase 2
Locations
United States
Study Type
Interventional
Intervention
BBI intervention
Sponsored by
About this trial
This is an interventional supportive care trial for Neoplasms
Eligibility Criteria
Inclusion Criteria:
- Females
- Stage I-IV gynecologic cancer (including ovarian, uterine, cervical, vulvar, or vaginal cancer)
- Undergoing active treatment or in remission and undergoing active surveillance; age ≥21 and ≤80
- Able to speak/read English.
Exclusion Criteria:
- Concurrent diagnosis of organic brain syndrome, dementia, mental retardation
- Non-English speaking, or significant sensory deficit
- Major mental illness (e.g., schizophrenia, psychotic disorder).
Sites / Locations
- Markey Cancer Center, University of Kentucky
Arms of the Study
Arm 1
Arm Type
Experimental
Arm Label
BBI Intervention
Arm Description
Biobehavioral Intervention
Outcomes
Primary Outcome Measures
Emotional distress as measured by Profile of Mood States score
Cancer specific traumatic stress as measured the by Impact of Events Scale score
Social support as measured by the Perceived Social Support from Family score
Physical activity as measured by the Godin-Shepard Leisure-Time Physical Activity Questionnaire score
Dietary habits as measured by the Food Habits Questionnaire
Sexual functioning as measured by the Sexual Experience Scale score
Pain as measured by the Brief Pain Questionnaire score
Fatigue as measured by the Fatigue Severity Index score
Sleep as measured by the Pittsburg Sleep Quality Index
Secondary Outcome Measures
Patient-reported evaluation of the BBI as measured by the Evaluation of Topics score
Therapist-reported fidelity/Usage of BBI as measured through logs
Full Information
1. Study Identification
Unique Protocol Identification Number
NCT02454036
Brief Title
Biobehavioral Intervention in Gynecologic Oncology Patients
Official Title
Psychological Changes in Cancer Patients Receiving a Biobehavioral Intervention: A Program Evaluation
Study Type
Interventional
2. Study Status
Record Verification Date
December 2017
Overall Recruitment Status
Completed
Study Start Date
June 2015 (undefined)
Primary Completion Date
May 18, 2017 (Actual)
Study Completion Date
May 18, 2017 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Sponsor-Investigator
Name of the Sponsor
Rachel Miller
4. Oversight
Data Monitoring Committee
Yes
5. Study Description
Brief Summary
Baseline self-report outcome measures will be completed and additional assessments will occur mid-treatment , post-treatment , 3 months following completion of all sessions, and 6 months following completion of all sessions. Patients and therapists will complete the evaluation measures in private (at home, in an office).
At the University of Kentucky Markey Cancer Center, BBI treatment is offered in group and individual formats. The course of individual treatment varies and group treatment consists of 10 1.5-hour weekly sessions in the "intensive" phase, followed by 2 1.5-hour bi-weekly maintenance sessions. Individual treatment is one-on-one. In group treatment, there are typically 6-12 patients per group and 1 or 2 therapists. The intervention helps patients to learn adaptive coping strategies and how to apply them to daily stressors. Additional content discusses use of seeking information, enhancing social support, enhancing body esteem and intimacy, and maintaining positive changes.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Neoplasms, Ovarian Neoplasms, Uterine Neoplasms, Vulva
7. Study Design
Primary Purpose
Supportive Care
Study Phase
Phase 2
Interventional Study Model
Single Group Assignment
Masking
None (Open Label)
Allocation
N/A
Enrollment
6 (Actual)
8. Arms, Groups, and Interventions
Arm Title
BBI Intervention
Arm Type
Experimental
Arm Description
Biobehavioral Intervention
Intervention Type
Behavioral
Intervention Name(s)
BBI intervention
Other Intervention Name(s)
Biobehavioral Intervention
Intervention Description
Psychological intervention designed to reduce stress and enhance quality of life
Primary Outcome Measure Information:
Title
Emotional distress as measured by Profile of Mood States score
Time Frame
Up to 6 months following completion of treatment
Title
Cancer specific traumatic stress as measured the by Impact of Events Scale score
Time Frame
Up to 6 months following completion of treatment
Title
Social support as measured by the Perceived Social Support from Family score
Time Frame
Up to 6 months following completion of treatment
Title
Physical activity as measured by the Godin-Shepard Leisure-Time Physical Activity Questionnaire score
Time Frame
Up to 6 months following completion of treatment
Title
Dietary habits as measured by the Food Habits Questionnaire
Time Frame
Up to 6 months following completion of treatment
Title
Sexual functioning as measured by the Sexual Experience Scale score
Time Frame
Up to 6 months following completion of treatment
Title
Pain as measured by the Brief Pain Questionnaire score
Time Frame
Up to 6 months following completion of treatment
Title
Fatigue as measured by the Fatigue Severity Index score
Time Frame
Up to 6 months following completion of treatment
Title
Sleep as measured by the Pittsburg Sleep Quality Index
Time Frame
Up to 6 months following completion of treatment
Secondary Outcome Measure Information:
Title
Patient-reported evaluation of the BBI as measured by the Evaluation of Topics score
Time Frame
Up to 6 months following completion of treatment
Title
Therapist-reported fidelity/Usage of BBI as measured through logs
Time Frame
Up to 6 months following completion of treatment
10. Eligibility
Sex
Female
Minimum Age & Unit of Time
21 Years
Maximum Age & Unit of Time
80 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
Females
Stage I-IV gynecologic cancer (including ovarian, uterine, cervical, vulvar, or vaginal cancer)
Undergoing active treatment or in remission and undergoing active surveillance; age ≥21 and ≤80
Able to speak/read English.
Exclusion Criteria:
Concurrent diagnosis of organic brain syndrome, dementia, mental retardation
Non-English speaking, or significant sensory deficit
Major mental illness (e.g., schizophrenia, psychotic disorder).
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Rachel Miller, MD
Organizational Affiliation
University of Kentucky
Official's Role
Principal Investigator
Facility Information:
Facility Name
Markey Cancer Center, University of Kentucky
City
Lexington
State/Province
Kentucky
ZIP/Postal Code
40536
Country
United States
12. IPD Sharing Statement
Learn more about this trial
Biobehavioral Intervention in Gynecologic Oncology Patients
We'll reach out to this number within 24 hrs